Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page’s revision tag has been updated to v3.5.4, indicating a new build. This reflects an incremental release rather than content changes.
    Difference
    0.0%
    Check dated 2026-05-15T23:52:41.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s interface revision/version label was updated from “v3.5.2” to “v3.5.3,” indicating a minor update to the ClinicalTrials.gov site software rather than a change to the trial record content.
    Difference
    0.0%
    Check dated 2026-04-24T16:44:17.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:31:30.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T18:59:17.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T14:58:53.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Version 3.4.2 (2026-02-03) adds Contacts/Locations and Study Status to the record history. The prior revision 3.4.0 (2025-10-06) was removed.
    Difference
    0.3%
    Check dated 2026-02-11T01:42:36.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.